ICCC

Companies
NASDAQ
ImmuCell Corporation
Health Care
Price Chart
Overview

About ICCC

immucell corporation is a biotechnology company based out of portland maine. immucell's focus is to create scientifically-proven and practical products that result in a measurable economical impact on animal health and productivity in the dairy and beed industries.

Market Cap
$35.1M
Volume
154.1K
Avg. Volume
212.8K
P/E Ratio
-47.909092
Dividend Yield
0.00%
Employees
61.0

Company Information

Exchange
NASDAQ
Sector
Health Care
Industry
Biotechnology
Risk & Correlation Analysis
Market Correlation
0.18
Low Correlation
Volatility
High (0.54)
Relative to market

Macro Factor Sensitivities

Interest Rates
Low Sensitivity
Inflation
Low Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Medium Sensitivity
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for ICCC.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, ICCC shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
Market Cap$35.1M
Volume154.1K
P/E Ratio-47.91
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
August 11, 2025
Related Securities

PortfolioPilot Analysis

Get AI-powered insights on how ICCC fits into your investment strategy and portfolio diversification.

Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025